Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae

Mika Halavaara; Annika Nevalainen; Timi Martelius; Pentti Kuusela; Veli-Jukka Anttila

doi:10.1016/j.diagmicrobio.2018.11.009

Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae

Mika Halavaara, Annika Nevalainen, Timi Martelius, Pentti Kuusela, Veli-Jukka Anttila

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Diagnostic Microbiology and Infectious Disease
Volym	94
Nummer	1
Sidor (från-till)	1-6
Antal sidor	6
ISSN	0732-8893
DOI	https://doi.org/10.1016/j.diagmicrobio.2018.11.009
Status	Publicerad - maj 2019
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1016/j.diagmicrobio.2018.11.009

1-s2.0-S0732889318303353-mainSlutlig publicerad version, 366 KB
Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpCKorrektur, 349 KB

Citera det här

Halavaara, M., Nevalainen, A., Martelius, T., Kuusela, P., & Anttila, V.-J. (2019). Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae. Diagnostic Microbiology and Infectious Disease, 94(1), 1-6. https://doi.org/10.1016/j.diagmicrobio.2018.11.009

@article{f1261af90ddc43f38ecbcff3cf843a0f,

title = "Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae",

keywords = "MALDI-TOF, Short incubation, Bacteremia, Bloodstream infection, Empiric antibiotic treatment, FLIGHT MASS-SPECTROMETRY, DESORPTION IONIZATION-TIME, RAPID PATHOGEN IDENTIFICATION, ANTIMICROBIAL THERAPY, PATIENT OUTCOMES, BACTEREMIA, CULTURES, MANAGEMENT, MICROORGANISMS, INTERVENTION, 3121 General medicine, internal medicine and other clinical medicine",

author = "Mika Halavaara and Annika Nevalainen and Timi Martelius and Pentti Kuusela and Veli-Jukka Anttila",

year = "2019",

month = may,

doi = "10.1016/j.diagmicrobio.2018.11.009",

language = "English",

volume = "94",

pages = "1--6",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",

number = "1",

}

Halavaara, M , Nevalainen, A , Martelius, T , Kuusela, P & Anttila, V-J 2019, 'Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae', Diagnostic Microbiology and Infectious Disease, vol. 94, nr. 1, s. 1-6. https://doi.org/10.1016/j.diagmicrobio.2018.11.009

Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae. / Halavaara, Mika ; Nevalainen, Annika ; Martelius, Timi et al.
I: Diagnostic Microbiology and Infectious Disease, Vol. 94, Nr. 1, 05.2019, s. 1-6.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae

AU - Halavaara, Mika

AU - Nevalainen, Annika

AU - Martelius, Timi

AU - Kuusela, Pentti

AU - Anttila, Veli-Jukka

PY - 2019/5

Y1 - 2019/5

KW - MALDI-TOF

KW - Short incubation

KW - Bacteremia

KW - Bloodstream infection

KW - Empiric antibiotic treatment

KW - FLIGHT MASS-SPECTROMETRY

KW - DESORPTION IONIZATION-TIME

KW - RAPID PATHOGEN IDENTIFICATION

KW - ANTIMICROBIAL THERAPY

KW - PATIENT OUTCOMES

KW - BACTEREMIA

KW - CULTURES

KW - MANAGEMENT

KW - MICROORGANISMS

KW - INTERVENTION

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1016/j.diagmicrobio.2018.11.009

DO - 10.1016/j.diagmicrobio.2018.11.009

M3 - Article

SN - 0732-8893

VL - 94

SP - 1

EP - 6

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 1

ER -